Allergan Spurns Ackman, Valeant’s $46 Billion Bid
Allergan formally rejected the $46 billion unsolicited takeover bid made by Valeant Pharmaceuticals, saying the proposal substantially undervalues the Botox maker. Dana Mattioli joins MoneyBeat. Photo: AP.
“Allergan Spurns Ackman, Valeant’s $46 Billion Bid” is categorized as “business”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.